Shu‐Wen Lin

1.4k total citations
76 papers, 1.1k citations indexed

About

Shu‐Wen Lin is a scholar working on Infectious Diseases, Epidemiology and Pharmacology. According to data from OpenAlex, Shu‐Wen Lin has authored 76 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Infectious Diseases, 24 papers in Epidemiology and 16 papers in Pharmacology. Recurrent topics in Shu‐Wen Lin's work include Pneumocystis jirovecii pneumonia detection and treatment (13 papers), Antibiotics Pharmacokinetics and Efficacy (13 papers) and HIV/AIDS drug development and treatment (12 papers). Shu‐Wen Lin is often cited by papers focused on Pneumocystis jirovecii pneumonia detection and treatment (13 papers), Antibiotics Pharmacokinetics and Efficacy (13 papers) and HIV/AIDS drug development and treatment (12 papers). Shu‐Wen Lin collaborates with scholars based in Taiwan, United States and China. Shu‐Wen Lin's co-authors include Ching‐Hua Kuo, Hsin‐Yun Sun, Peggy L. Carver, I‐Lin Tsai, Guan‐Yuan Chen, Chien‐Ching Hung, Daryl D. DePestel, Li‐Jiuan Shen, Chi‐Chuan Wang and Chien‐Chih Wu and has published in prestigious journals such as PLoS ONE, Analytical Chemistry and Clinical Infectious Diseases.

In The Last Decade

Shu‐Wen Lin

73 papers receiving 1.0k citations

Peers

Shu‐Wen Lin
Torsten Hoppe‐Tichy Germany
Kevin J. Downes United States
Tony Whitehouse United Kingdom
Sarah C J Jorgensen Canada
Paul M. Beringer United States
José Ramón Azanza Perea Spain
Linda Dresser Canada
Ronald G. Hall United States
Stefan Hagel Germany
Alfonso Domínguez‐Gil Spain
Torsten Hoppe‐Tichy Germany
Shu‐Wen Lin
Citations per year, relative to Shu‐Wen Lin Shu‐Wen Lin (= 1×) peers Torsten Hoppe‐Tichy

Countries citing papers authored by Shu‐Wen Lin

Since Specialization
Citations

This map shows the geographic impact of Shu‐Wen Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shu‐Wen Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shu‐Wen Lin more than expected).

Fields of papers citing papers by Shu‐Wen Lin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shu‐Wen Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shu‐Wen Lin. The network helps show where Shu‐Wen Lin may publish in the future.

Co-authorship network of co-authors of Shu‐Wen Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Shu‐Wen Lin. A scholar is included among the top collaborators of Shu‐Wen Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shu‐Wen Lin. Shu‐Wen Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Song, Junmin, Kuan-Yu Chi, Yu‐Ling Chang, et al.. (2025). Statin and Immune-Related Cardiovascular Events in Lung Cancer Patients Receiving Immune Checkpoint Inhibitors. Oncology. 104(3). 319–326. 2 indexed citations
2.
Su, Faye, Chengcheng Liu, Zehui Lv, et al.. (2025). Global research trends in artificial intelligence in cardiovascular medicine: A bibliometric analysis. Archives of cardiovascular diseases. 119(2). 162–175.
3.
Yang, Jing‐Wen, et al.. (2025). Preference for HIV testing among community residents in Yunnan Province, China: results from a discrete choice experiment. BMC Health Services Research. 25(1). 216–216. 1 indexed citations
4.
Lin, Fang‐Ju, et al.. (2024). The Impact of QT‐Prolonging Medications and Drug–Drug Interactions on QTc Interval Prolongation in Hospitalized Patients: A Case‐Crossover Study. Clinical Pharmacology & Therapeutics. 117(2). 495–505. 2 indexed citations
5.
Hou, Hsin‐An, Chien‐Chin Lin, Ching‐Hua Kuo, et al.. (2024). Early Therapeutic Drug Monitoring Optimizes Teicoplanin Use in Febrile Neutropenic Patients with Hematological Malignancies. Advances in Therapy. 41(7). 2966–2977. 1 indexed citations
6.
Chiang, Yi‐Hsuan, Yee‐Chun Chen, Yijing Chen, et al.. (2023). Enhancing the identification of voriconazole-associated hepatotoxicity by targeted metabolomics. International Journal of Antimicrobial Agents. 63(1). 107028–107028. 5 indexed citations
7.
Lin, Hung‐Yu, Fei‐Yuan Hsiao, Shih‐Tsung Huang, et al.. (2023). Longitudinal impact of distinct infection trajectories on all-cause mortality of older people in Taiwan: a retrospective, nationwide, population-based study. The Lancet Healthy Longevity. 4(9). e508–e516. 6 indexed citations
8.
Lin, Shu‐Yung, Jia‐Yih Feng, Chih‐Yuan Lee, et al.. (2020). Completion and Adverse Drug Events of Latent Tuberculosis Infection Treatment in Patients Receiving Dialysis: Predictors and Impacts of Different Regimens in a Prospective Cohort Study. Antimicrobial Agents and Chemotherapy. 65(3). 1 indexed citations
9.
Liu, Wang-Da, Shu‐Wen Lin, Ming‐Chieh Shih, et al.. (2020). False-positive Aspergillus galactomannan immunoassays associated with intravenous human immunoglobulin administration. Clinical Microbiology and Infection. 26(11). 1555.e9–1555.e14. 13 indexed citations
10.
Lin, Shu‐Wen, Chih‐Yuan Lee, Yu‐Feng Wei, et al.. (2020). CD4 response of QuantiFERON-TB Gold Plus for positive consistency of latent tuberculosis infection in patients on dialysis. Scientific Reports. 10(1). 21367–21367. 3 indexed citations
11.
Lee, Meng‐Rui, Hung‐Ling Huang, Shu‐Wen Lin, et al.. (2019). Isoniazid Concentration and NAT2 Genotype Predict Risk of Systemic Drug Reactions during 3HP for LTBI. Journal of Clinical Medicine. 8(6). 812–812. 21 indexed citations
12.
13.
Huang, Sung‐Hsi, Shu‐Wen Lin, Sui‐Yuan Chang, et al.. (2017). Prediction of plasma efavirenz concentrations among HIV-positive patients taking efavirenz-containing combination antiretroviral therapy. Scientific Reports. 7(1). 16187–16187. 7 indexed citations
14.
15.
Lin, Kuan‐Yin, Sih‐Han Liao, Wen‐Chun Liu, et al.. (2015). Cholelithiasis and Nephrolithiasis in HIV-Positive Patients in the Era of Combination Antiretroviral Therapy. PLoS ONE. 10(9). e0137660–e0137660. 10 indexed citations
16.
Chiu, Hsien‐Yi, Tiange Wang, Chang‐Chuan Chan, Shu‐Wen Lin, & Tsen‐Fang Tsai. (2015). Risk Factor Analysis for the Immunogenicity of Adalimumab Associated with Decreased Clinical Response in Chinese Patients with Psoriasis. Acta Dermato Venereologica. 95(6). 711–716. 22 indexed citations
17.
Lee, Yi‐Chieh, Shu‐Wen Lin, Mao-Yuan Chen, et al.. (2015). Presence of Tablet Remnants of Nevirapine Extended-Release in Stools and Its Impact on Virological Outcome in HIV-1-Infected Patients: A Prospective Cohort Study. PLoS ONE. 10(10). e0140574–e0140574. 2 indexed citations
18.
Lin, Shu‐Wen, et al.. (2014). New knowledge-based genetic algorithm for excavator boom structural optimization. Chinese Journal of Mechanical Engineering. 27(2). 392–401. 5 indexed citations
19.
Wu, Fe‐Lin Lin, et al.. (2012). Effectiveness of Education Programs About Oral Antibiotic Suspensions in Pediatric Outpatient Services. Pediatrics & Neonatology. 54(1). 34–42. 24 indexed citations
20.
Wu, Fe‐Lin Lin, Shu‐Wen Lin, Chyi-Huey Bai, et al.. (2012). Age, dementia and care patterns after admission for acute coronary syndrome: an analysis from a nationwide cohort under the National Health Insurance coverage.. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Torsten Hoppe‐Tichy Breakdown of academic impact, for papers by Kevin J. Downes Breakdown of academic impact, for papers by Tony Whitehouse Breakdown of academic impact, for papers by Sarah C J Jorgensen Breakdown of academic impact, for papers by Paul M. Beringer Breakdown of academic impact, for papers by José Ramón Azanza Perea Breakdown of academic impact, for papers by Linda Dresser Breakdown of academic impact, for papers by Ronald G. Hall Breakdown of academic impact, for papers by Stefan Hagel Breakdown of academic impact, for papers by Alfonso Domínguez‐Gil
Rankless by CCL
2026